-transparent.png){kind=logo}
Fifty-four patients with non-small cell lung cancer were treated with a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). A 35% response rate was seen, with a median survival of 380 days for the responders, compared to median survival times of 150 days for the nonresponders and 229 days for the group. Twenty-four percent of these patients had received prior treatment. All of the nonresponding patients had died by 438 days, whereas eight of 19 responders lived greater than 425 days. The survival curve the nonresponders was similar to that for a historical control group not given chemotherapy. These data indicate that this drug regimen has some efficacy in the treatment of non-small cell lung cancer.
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
April 1983,
Cancer treatment reports,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
August 1987,
Tumori,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
March 1991,
Gan to kagaku ryoho. Cancer & chemotherapy,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
September 1984,
Cancer treatment reports,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
February 1982,
Cancer treatment reports,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
November 1989,
Cancer,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
January 1981,
Cancer treatment reports,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
January 1992,
Cancer chemotherapy and pharmacology,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
October 1987,
Cancer treatment reports,
J A Knost, and
F A Greco, and
K R Hande, and
R L Richardson, and
M F Fer, and
R K Oldham
February 1986,
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
